To verify the role of GPR43 in mediating inhibitory effects on Th1 cells in colitis, we used the GPR43 inhibitor GLPG0974 to block GPR43 activity in EGCG-treated mice (Fig. 4A). Here, FFAR2 is linked to colitis.